Advertisement

Topics

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

11:51 EST 1 Feb 2018 | FinanzNachrichten

This publication is part of Frost & Sullivan's independent equity research service TEL AVIV, Israel, Feb. 1, 2018 /PRNewswire/ -- Summary of Highlights On January 29, 2018, Cellect announced that ...

Original Article: Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

NEXT ARTICLE

More From BioPortfolio on "Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged"

Advertisement
Quick Search
Advertisement
Advertisement